Description
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) consisting of 44 amino acids with a trans-3-hexenoic acid modification at the N-terminus, supplied as a research-grade, lyophilized reagent for laboratory and in-vitro research into growth hormone regulation and neuroendocrine pathways. The N-terminal modification confers increased resistance to enzymatic degradation by DPP-IV compared to native GHRH(1-44), extending the peptide biological half-life while preserving receptor binding affinity. Every vial is characterized by independent third-party testing for identity and purity, packaged under controlled conditions, and shipped from North America with a lot-specific certificate of analysis available on request. Intended exclusively for use by qualified researchers and laboratory personnel. For research use only, not for human consumption, not for injection, and not for therapeutic use. Classification, handling, and suitability for any specific application are the responsibility of the purchasing institution.

Reviews
There are no reviews yet.